Vertexynbio
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 1
About Vertexynbio
, trading as Vertexynbio, focuses on engineering biotechnology and biomanufacturing. The company has since expanded its portfolio to cover multiple fields, including pharmaceutical raw materials, natural cosmetic ingredients, functional foods, and bio-based colorants, integrating research and commercialization. The company develops and manufactures bio-based raw materials through synthetic biology and biomanufacturing technologies. Its portfolio spans pharmaceutical intermediates, natural ingredients for daily-use chemical products, functional food additives, and novel bio-based pigments. These products are positioned to meet demand in the healthcare, nutrition, agriculture, and consumer goods sectors. The company generates revenue from the sales of bio-based raw materials and ingredients across pharmaceuticals, personal care, food, nutrition, and agriculture, supported by its research-driven product development and manufacturing operations.
Who invested in Vertexynbio
1 investor across 1 round
See all investors in Vertexynbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 10, 2025
Amount
Undisclosed
Investors
Questions about Vertexynbio
Who invested in Vertexynbio?
Vertexynbio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vertexynbio raised?
Vertexynbio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vertexynbio last raise money?
Vertexynbio's most recent round on record is a Series B, in Nov 2025.
What does Vertexynbio do?
, trading as Vertexynbio, focuses on engineering biotechnology and biomanufacturing.
Where is Vertexynbio headquartered?
Vertexynbio is headquartered in Xuzhou, China.
Which VCs invest in companies like Vertexynbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Vertexynbio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vertexynbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.